![The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant](https://thenativeantigencompany.com/wp-content/uploads/2022/11/iStock-1206774789_Coronavirus-Virus-Outbreak-7882x3900-1-1080x675.jpeg)
![The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant](https://thenativeantigencompany.com/wp-content/uploads/2022/11/iStock-1206774789_Coronavirus-Virus-Outbreak-7882x3900-1-1080x675.jpeg)
![The Role of Serology in Tracking COVID-19 Mutations](https://thenativeantigencompany.com/wp-content/uploads/2021/08/Coronavirus-148-1.jpg)
The Role of Serology in Tracking COVID-19 Mutations
This article was originally published on Clinical Lab Products. As SARS-CoV-2 began its global proliferation in early 2020, scientists hastened to investigate its biology, develop diagnostic tests, and design candidate vaccines, marking one of the most...![Preparing for Disease Y: A Better Serological Toolbox](https://thenativeantigencompany.com/wp-content/uploads/2021/07/shutterstock_404227879-1.jpg)
Preparing for Disease Y: A Better Serological Toolbox
This article was originally published on Clinical Lab Manager. It’s been over a year since the World Health Organization (WHO) declared COVID-19 a pandemic. SARS-CoV-2 has since infected 200 million people, resulting in nearly 4 million deaths and substantial economic...![Keeping Up with the New SARS-CoV-2 Variant Nomenclature](https://thenativeantigencompany.com/wp-content/uploads/2021/06/shutterstock_1911593662.jpg)
Keeping Up with the New SARS-CoV-2 Variant Nomenclature
If you’ve been struggling to make sense of SARS-CoV-2 variant nomenclature, you’re not alone. Due to the existence of multiple genomic sequence databases, various naming systems are in use for the rapidly growing range of SARS-CoV-2 variants of concern/interest. In a...![Making Sense of the SARS-CoV-2 Spike Mutations](https://thenativeantigencompany.com/wp-content/uploads/2021/03/shutterstock_1941307915.jpg)
Making Sense of the SARS-CoV-2 Spike Mutations
Through much of 2020, SARS-CoV-2 accumulated mutations at a steady, yet unspectacular rate. However, as global cases approached 100 million by the end of the year, multiple variants began to emerge. Exhibiting more considerable genomic changes, some variants have...![D614G: Putting the Mutation in Perspective](https://thenativeantigencompany.com/wp-content/uploads/2020/11/shutterstock_1685385064.jpg)